Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most adults injecting Wegovy, pinching the skin is not strictly required, but it can make the injection more comfortable and easier to do correctly. The Wegovy pre-filled pen is designed to deliver semaglutide into the subcutaneous layer — the fatty tissue just beneath the skin — and whether you need to lift the skin first depends largely on your body composition and the injection site you choose. These are prescription-only medicines, and your prescriber will tailor technique guidance to your individual circumstances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before deciding whether to pinch, settle on an injection site. Wegovy can be given in the abdomen (at least a few centimetres from the navel), the front of the thigh, or the upper arm. Rotate these sites each week so no single area is used repeatedly. The NHS guidance on semaglutide notes that subcutaneous injections go into the fatty tissue directly beneath the skin, not the muscle below it.
Once you have chosen your site, consider how much subcutaneous tissue is present there. On the abdomen there is usually a reasonable layer, so many people can inject comfortably without pinching. On the thigh, particularly in people who carry less body fat in the legs, the gap between skin and muscle can be narrower, and pinching becomes more useful. The upper arm is similar, some people find it difficult to create a fold there one-handed, which is worth thinking about before making it your regular spot. If you want a fuller picture of site options, our guide to injecting Wegovy in the arm covers the upper-arm specifics in more detail.
There is a common misconception that you must always pinch for any subcutaneous injection. That is not true. Pinching is a tool, not a rule, and for someone with plenty of subcutaneous tissue at the chosen site, it may add no benefit at all. If you are weighing up whether you should pinch your skin when injecting Wegovy, the answer genuinely depends on your individual body composition and chosen site. Let that concern go if it has been nagging at you.
If you judge that a skin fold will help, the method is straightforward. Using your thumb and two fingers, lift a firm fold of skin (not just the surface) roughly two to three centimetres wide. Hold it gently but steadily throughout the injection; releasing too early can allow the needle to shift. Insert the pen at a 90-degree angle to the skin fold, press the injection button, and hold for the count of ten seconds before withdrawing. The ten-second hold is important because it allows all the medicine to be delivered and reduces the small chance of leakage at the skin surface.
Once the needle is withdrawn, you can release the skin fold. A light press with a clean finger (not rubbing) helps if there is any minor discomfort. You do not need to recap the needle, the Wegovy pen has a safety shield that covers it automatically. Disposing of the used pen correctly matters: a sharps container is the right place for it, not the household bin.
For a broader walkthrough of the whole injection process, our full guide to injecting Wegovy covers preparation, storage, and what to do if you notice anything unusual after your dose.
One aspect of injection technique that is easy to overlook: your body will likely change shape over the course of treatment, and your technique may need to change with it. Someone who began Wegovy with ample abdominal fat may find after several months that the subcutaneous layer at their preferred site is thinner. At that point, understanding whether to pinch the skin when injecting Wegovy becomes a more pressing practical question, and introducing a skin fold or switching to a different site may both be worth considering.
This is exactly the kind of practical question worth raising at a clinical review. Semaglutide (Wegovy) is a prescription medicine, and the clinical oversight that comes with a legitimate prescription service exists precisely for ongoing questions like this, not only for the first prescription. The NHS patient information for semaglutide is a reliable reference point for general technique, and the Patient Information Leaflet supplied with each pen should always be read in full.
If you are still exploring what Wegovy involves (how it works, who it is suitable for, and the differences from other licensed options) our Wegovy overview is a good starting point, and you can explore all available weight-loss treatments to see the broader picture. If cost is a consideration, our honest guide to Wegovy pricing in the UK explains what is typically included in a legitimate private price.
Wegovy is a prescription-only medicine. If you would like a clinician to assess your suitability and answer your technique questions from the start, check your eligibility with our prescribers, the consultation is free, and a GPhC-registered Independent Prescriber reads every response the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.